Invitation to presentation of Bactiguard’s year end report for 2015 on February 18

Bactiguard Holding AB publishes the year end report for 2015 on
Thursday February 18 at 08:00 CET
In connection with this, a conference call for investors, analysts and media
will be held at 10:00 CET on February 18. CEO Christian Kinch and CFO Fredrik
Järrsten will present the report and answer questions.

The year end report will be available at Bactiguard’s website www.bactiguard.com
from 08:00 CET the same day.

To participate in the conference call, please dial +46 8 566 427 00
For further information, please contact:
Ulrika Berglund, Head of External Affairs, mobile: 46 708 800 407

For questions about participation in the conference call, please contact:
Susann Remnert, Communication Manager, mobile: +46 709 195 342
e-mail: susann.remnert@bactiguard.se
About Bactiguard
Bactiguard is a Swedish medtech company with a global presence, offering a
solution that prevents healthcare associated infections caused by medical
devices. By preventing infections, we contribute to a reduced use of antibiotics
and the spread of multi-resistant bacteria, which is a growing problem
worldwide. We save lives, increase patient safety and significantly reduce the
cost for the healthcare and society. Our technology is well-proven, safe and
tissue friendly and consist of a thin layer of noble metals that prevents
bacterial growth. The coating can be applied on almost all medical devices.
Bactiguard-coated urinary catheters are market leading in the US and Japan and
the company has also its own product portfolio consisting of Foley catheters,
central venous catheters and endotracheal tubes. Bactiguard is a growth company,
focused on markets in Europe, Middle East, Asia and Latin America. The company
has about 70 employees worldwide, mainly at the headquarters in Stockholm and
the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more
about Bactiguard at www.bactiguard.com